If the FDA approves it — the world will be changed forever

It could be the biggest medical breakthrough in history... It could be the biggest medical breakthrough in history... Energy and Capital: Practical Investment Analysis in the new Energy Economy [Energy and Capital logo] If the FDA approves it — the world will be changed forever By Keith Kohl | March 19, 2022 - Baltimore, MD Take a look at this picture: [tao anti aging pill video]( On the surface, this pill looks just like any other… But don’t be fooled. Inside is a [revolutionary new technology]( that The Guardian reports could: "spell the end of aging"— The Guardian And Scientific American says it could allow anyone that takes it to: "stay young [forever]"— Scientific American This pill is set to completely change the lives of millions of Americans... And because just [one tiny Brisbane company]( has virtually monopolized this technology with 140 foolproof patents... Investors who get in on the ground floor stand to become rich beyond their wildest dreams. [Here are all the details.]( Sincerely, [keith-kohl-signature-transparent] Keith Kohl Investment Director, Technology and Opportunity --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2022, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.](